Robert Taub

Robert Taub discloses dealings in Omrix Biopharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 30 November 2006 to 23 November 2008, the count stands at 6 filings.

Both buying and selling appear: 2 purchases worth €629k, against 2 sales worth €18.0M. Netting one side against the other leaves €17.3M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 share grants. Since January 2008: 2 purchases and no sales on the market.

The record was last updated on 25 November 2008 with a share grant in Omrix Biopharmaceuticals, Inc. The clock since the last published purchase (20 March 2008) now reads 6,792 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.